Adaptive Biotechnologies Corporation
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $352.9M | $661.1M | $65.1M |
| FY2024 | $336.9M | $539.4M | $47.9M |
| FY2025 | $287.7M | $512.7M | $70.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $352.9M | $661.1M | $65.1M |
| FY2024 | $336.9M | $539.4M | $47.9M |
| FY2025 | $287.7M | $512.7M | $70.5M |